$13.60
-0.35-2.51%
Pre-Market: 5:13 AM EDT
Comments
Loading...
Avanos Medical Stock Guidance | NYSE:AVNS | Benzinga
Avanos Medical issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | AVNS | Avanos Medical | FY | 2025 | $1.05 | $1.25 | $1.67 | $665.00M | $685.00M | $713.13M | Get Alert |
| 01/13/2025 | AVNS | Avanos Medical | Q4 | 2024 | $0.38 | $0.43 | $0.40 | $175.00M | $180.00M | $177.23M | Get Alert |
| 10/30/2024 | AVNS | Avanos Medical | FY | 2024 | $1.30 | $1.35 | $1.39 | $683.00M | $688.00M | $695.23M | Get Alert |
| 07/31/2024 | AVNS | Avanos Medical | FY | 2024 | $1.30 | $1.45 | $1.37 | $685.00M | $705.00M | $695.40M | Get Alert |
| 05/02/2024 | AVNS | Avanos Medical | FY | 2024 | $1.30 | $1.45 | $1.38 | $685.00M | $705.00M | $691.00M | Get Alert |
| 02/20/2024 | AVNS | Avanos Medical | FY | 2024 | $1.30 | $1.45 | — | $685.00M | $705.00M | — | Get Alert |
| 01/04/2024 | AVNS | Avanos Medical | FY | 2024 | — | — | — | $685.00M | $705.00M | $714.43M | Get Alert |
| 01/04/2024 | AVNS | Avanos Medical | FY | 2023 | — | — | — | $670.00M | $673.00M | $679.27M | Get Alert |
| 01/04/2024 | AVNS | Avanos Medical | Q4 | 2023 | — | — | — | $170.00M | $173.00M | $179.27M | Get Alert |
| 11/01/2023 | AVNS | Avanos Medical | FY | 2023 | $1.05 | $1.15 | $1.09 | $675.00M | $685.00M | $680.63M | Get Alert |
| 08/09/2023 | AVNS | Avanos Medical | FY | 2023 | $1.05 | $1.15 | $1.52 | — | — | — | Get Alert |
| 06/20/2023 | AVNS | Avanos Medical | FY | 2023 | $1.60 | $1.70 | $1.66 | $805.00M | $805.00M | $802.47M | Get Alert |
| 06/20/2023 | AVNS | Avanos Medical | Q2 | 2023 | $0.32 | $0.36 | $0.32 | $193.00M | $196.00M | $194.40M | Get Alert |
| 05/03/2023 | AVNS | Avanos Medical | FY | 2023 | $1.60 | $1.80 | $1.70 | — | — | — | Get Alert |
| 02/21/2023 | AVNS | Avanos Medical | FY | 2023 | $1.60 | $1.80 | $1.68 | — | — | — | Get Alert |
| 11/02/2022 | AVNS | Avanos Medical | FY | 2022 | $1.45 | $1.65 | $1.51 | $815.00M | $835.00M | $824.62M | Get Alert |
| 08/09/2022 | AVNS | Avanos Medical | FY | 2022 | $1.45 | $1.65 | $1.64 | $815.00M | $835.00M | $841.40M | Get Alert |
| 05/04/2022 | AVNS | Avanos Medical | FY | 2022 | $1.55 | $1.75 | $1.64 | $830.00M | $850.00M | $842.09M | Get Alert |
| 02/23/2022 | AVNS | Avanos Medical | FY | 2022 | $1.55 | $1.75 | $1.52 | $830.00M | $850.00M | $780.32M | Get Alert |
| 11/02/2021 | AVNS | Avanos Medical | FY | 2021 | $1.10 | $1.20 | $1.14 | — | — | — | Get Alert |
| 08/03/2021 | AVNS | Avanos Medical | FY | 2021 | $1.10 | $1.20 | $1.21 | $729.10M | $743.39M | $741.22M | Get Alert |
| 05/07/2021 | AVNS | Avanos Medical | FY | 2021 | $1.10 | $1.25 | $1.19 | $729.10M | $743.39M | $738.32M | Get Alert |
FAQ
What is the most recent guidance for Avanos Medical (AVNS)?
The most recent guidance for Avanos Medical (AVNS) was reported on February 26, 2025 for the full year 2025. The company provided earnings per share guidance in the range of $1.05 to $1.25, compared to the estimated EPS of $1.67. Additionally, Avanos Medical forecasted revenue between $0.67B and $0.69B for the quarter.
Browse guidance and forecast on all stocks.